Durvalumab-related interstitial pneumonia

Case contributed by Fabien Ho
Diagnosis almost certain

Presentation

Bronchial carcinoma PD-L1+ in the right upper lobe treated with radiotherapy and chemotherapy then with immunotherapy (durvalumab).

Patient Data

Age: 50 years
Gender: Male

Onset: 6 mth after in...

ct

Onset: 6 mth after initiation of durvalumab

Bilateral GGO forming circles, creating the "reversed halo" or "atoll" signs suggesting an organising pneumonia pattern.

1 month later

ct

GGO with similar OP pattern, non migratory, but fading compared to previous CT.

3 months later

ct

Emerging peripheral subpleural reticulations and GGO, asymmetrically, with left predominance, and traction bronchiectasis.

In some areas, there is a subpleural thin line of spared lung parenchyma typical of the fibrotic NSIP pattern.

Case Discussion

This is a case of immune checkpoint inhibitor therapy-related pneumonitis with durvalumab, an anti-PD-L1 binding human monoclonal antibody, which allows T lymphocyte activation and cytotoxic function towards tumours expressing PD-L1 surface protein.

At the onset of the pneumonitis, the atoll / reversed halo signs were highly suggestive of organised pneumonia pattern. BAL was not performed although it would have been advised to do so to rule out mucormycosis-related pneumonia, which also features atoll / reversed halo signs.
Upon follow-up, the patient developed an NSIP pattern.

How to use cases

You can use Radiopaedia cases in a variety of ways to help you learn and teach.

Creating your own cases is easy.